DANVILLE, Pennsylvania: Using tens of thousands of records from its own volunteer patient biobank, officials at Geisinger and scientists at partner Regeneron Genetics Center discovered a gene variant that shows a significant reduction in the risk liver disease, a breakthrough discovery that could lead to uncharted treatment options.

The findings of the study were released on Thursday (Friday in Manila) in the New England Journal of Medicine.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details